Roumell Asset Management, LLC / ENZB
Roumell Asset Management, LLC’s Enzo Biochem Inc Position
Does Roumell Asset Management, LLC own Enzo Biochem Inc (ENZB)? Not currently — the last reported position was 681.4K shares worth $1M in Q2 2023; the fund’s latest 13F (Q2 2024) no longer reports it.
Position Value
$1M
Q2 2023
Shares
681.4K
% of Portfolio
+2.46%
Quarters Held
16
position exited
Position History ENZB
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 681.4K | $1M | +2.46% |
| Q1 2023 | 905.3K | $2M | +4.98% |
| Q4 2022 | 2.13M | $3M | +7.54% |
| Q3 2022 | 2.39M | $5M | +11.54% |
| Q2 2022 | 2.39M | $5M | +9.63% |
| Q1 2022 | 2.39M | $7M | +11.21% |
| Q4 2021 | 2.44M | $8M | +10.43% |
| Q3 2021 | 2.89M | $10M | +13.54% |
| Q2 2021 | 2.89M | $9M | +10.69% |
| Q1 2021 | 2.74M | $9M | +13.61% |
| Q4 2020 | 2.77M | $7M | +10.97% |
| Q3 2020 | 2.35M | $5M | +9.85% |
| Q2 2020 | 611.8K | $1M | +3.30% |
| Q2 2019 | 1.24M | $4M | +9.86% |
| Q1 2019 | 1.90M | $5M | +12.61% |
| Q4 2018 | 1.11M | $3M | +6.35% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Roumell Asset Management, LLC’s full portfolio or all institutional holders of ENZB.